Evidence map›Paper›PMID 19649259›Full record

ArticlePloS one2009

Host responses to intestinal microbial antigens in gluten-sensitive mice.

Jane M Natividad, Xianxi Huang, Emma Slack, Jennifer Jury, Yolanda Sanz, Chella David, Emmanuel Denou, Pinchang Yang, Joseph Murray, Kathy D McCoy and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03664531 (Crossover Trial of Purified Gluten and Whole Wheat), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03664531 nacompletednot on this mapstarted 2019, after this paper: background citation

Crossover Trial of Purified Gluten and Whole Wheat (Gluten With Amylase-trypsin Inhibitors) as Triggers of Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome

TypeinterventionalSponsorMcMaster UniversityRan2019 to 2023Enrolled29ConditionsIrritable Bowel SyndromeArmsPurified gluten, Non-purified gluten (containing ATIs), Sham
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Bacteria: Potential Make-or-Break Determinants of Celiac Disease.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. The Infant-DerivedMicroorganisms · 2020
    Article
  8. Review
  9. Review
  10. Review
  11. The intestinal epithelial barrier: a therapeutic target?Nature reviews. Gastroenterology & hepatology · 2017
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Jane M NatividadFarncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Canada.
Xianxi Huang
Emma Slack
Jennifer Jury
Yolanda Sanz
Chella David
Emmanuel Denou
Pinchang Yang
Joseph Murray
Kathy D McCoy
Elena F Verdú
McMaster University · CAPopulation Health Research Institute · CAMayo Clinic · USConsejo Superior de Investigaciones Científicas · ES

Funding

A HLA Mouse Model for Gluten Sensitivity and EnteropathyR01DK071003 · NIDDK · MAYO CLINIC ROCHESTER · PI MURRAY, JOSEPH A · 2006 to 2009
$1.1M
NIDDK NIH HHS R01 DK071003NIDDK NIH HHS R01 DK71003
6 · The paper itself

Abstract

BACKGROUND AND

aimsExcessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice. METHODOLOGY/PRINCIPAL

findingsHLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T-cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-gamma in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota.

conclusionIndomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-gamma production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.

Indexed as

AnimalsAntigens, BacterialCadherinsGlutensHLA-DQ AntigensIndomethacinIntestinesMiceRNA, MessengerAntigens, BacterialCadherinsGlutensHLA-DQ8 antigenHLA-DQ AntigensIndomethacinRNA, Messenger

Identifiers

PMID19649259
PMCPMC2715133
OpenAlexW2161402890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.